mda-mb-468 (ATCC)
99
Structured Review
ATCC
mda-mb-468
Mda Mb 468, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 5703 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mda+mb+468/MDA-MB-468/custom%40htb-132%4042472092
Average 99 stars, based on 5703 article reviews
Mda Mb 468, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 5703 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mda+mb+468/MDA-MB-468/custom%40htb-132%4042472092
Average 99 stars, based on 5703 article reviews
mda-mb-468 - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Multiple Displacement Amplification:Article Title: Distinguishing cancerous from non-malignant breast cells using viscoelastic creep and functional principal component analysis. Article Snippet: The culture medium was supplemented with 5% horse serum (Invitrogen, Carlsbad, CA), 0.2% amphotericin (Gemini Bio-Products, West Sacramento, CA), 30 ng/ml insulin (Sigma-Aldrich, St. Louis, MO), 100 ng/ml cholera toxin (Sigma Aldrich), 30 ng/ml murine epidermal growth factor (PeproTech), 0.5 μg/ml hydrocortisone (Sigma Aldrich), and 1% Penicillin-Streptomycin (Invitrogen, Carlsbad, CA). .. The Article Title: Tumor-educated macrophages promote cytokine-driven lung colonization in triple-negative breast cancer Article Snippet: .. Article Title: Impact of germline RAD51D mutations on breast cancer: Susceptibility to DNA-damaging agents Article Snippet: .. The human TNBC cell lines MDA-MB-231 (ATCC, HTB-26) and Article Title: C1q-targeting bispecific antibodies bypass Fc to trigger complement activation and receptor clustering agonism. Article Snippet: .. Human B cell lymphoma cell lines Ramos (CRL− 1596), Raji (CCL− 86) and WIL2S-SF (serum-free derivative of WIL2-S; CRL− 8885), and human mammary gland adenocarcinoma cell lines AU565 (CRL− 2351) and Article Title: Synergistic dual targeting of mTOR and GLS1 overcomes glutamine-driven resistance in triple-negative breast cancer. Article Snippet: .. 4T1 (Procell, Wuhan, China), MDA-MB-231, Article Title: Inhibition of PTCH1 drug efflux activity enhances chemotherapy efficacy against triple negative breast cancers Article Snippet: Doxorubicin hydrochloride and docetaxel were purchased from Sigma-Aldrich and Acros-Organics, respectively. .. Human breast cancer cell lines MDA-MB-231, Article Title: Targeting SIK2 with GRN-300 Potentiates Paclitaxel Efficacy in Triple-Negative Breast Cancer. Article Snippet: .. Human breast cancer cell lines (MDA-MB-231 (MB-231), MDA-MB-436 (MB-436), Cell Culture:Article Title: Distinguishing cancerous from non-malignant breast cells using viscoelastic creep and functional principal component analysis. Article Snippet: The culture medium was supplemented with 5% horse serum (Invitrogen, Carlsbad, CA), 0.2% amphotericin (Gemini Bio-Products, West Sacramento, CA), 30 ng/ml insulin (Sigma-Aldrich, St. Louis, MO), 100 ng/ml cholera toxin (Sigma Aldrich), 30 ng/ml murine epidermal growth factor (PeproTech), 0.5 μg/ml hydrocortisone (Sigma Aldrich), and 1% Penicillin-Streptomycin (Invitrogen, Carlsbad, CA). .. The Article Title: Impact of germline RAD51D mutations on breast cancer: Susceptibility to DNA-damaging agents Article Snippet: .. The human TNBC cell lines MDA-MB-231 (ATCC, HTB-26) and Modification:Article Title: Impact of germline RAD51D mutations on breast cancer: Susceptibility to DNA-damaging agents Article Snippet: .. The human TNBC cell lines MDA-MB-231 (ATCC, HTB-26) and other:Article Title: Squamous-state excursions activate APOBEC3A in cancer Article Snippet: For pan-cell line analysis of APOBEC3A and APOBEC3B expression, AU565, BT20,BT-474, Cama1, DU4475, HCC1395, HCC1428, HCC1500, HCC1599, HCC1806, HCC1937, HCC1954, HCC202, HCC2157, HCC2218, HCC38, HCC70, Hs578T, MCF10A, MCF10F, MCF12A, MCF7, MDA-MB-157, MDA-MB-175-VII, MDA-MB-231, MDA-MB-361, MDA-MB-415, MDA-MB-436, MDA-MB-453, MDA-MB-468, SKBR3, T47D, UACC893, and |